Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 352.17 million Euro [US$407.61 million]
of which 56%
(807.12 million Euro [US$934.17 million]
of which 47%
was X-rays), and
(617.54 million Euro [US$714.75 million]
of which 50%
was Non-Proprietary Homeopathic Medicines).
Virbac reported sales of 861.88 million Euro (US$997.55 million)
December of 2017.
decrease of 1.1%
versus 2016, when the company's sales were 871.83 million Euro.
Contributing to the drop in overall sales was the 6.5% decline
in Companion Animals, from 508.20 million Euro to 475.40 million Euro.
However, these declines were partially offset by the increase in sales of
Food Productsing Annimal (up 5.8% to 375.20 million Euro)
Other (up 25.8% to 11.20 million Euro)